These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 1659437)
1. Lack of an interaction between propranolol and sumatriptan. Scott AK; Walley T; Breckenridge AM; Lacey LF; Fowler PA Br J Clin Pharmacol; 1991 Nov; 32(5):581-4. PubMed ID: 1659437 [TBL] [Abstract][Full Text] [Related]
2. Lack of effect of flunarizine on the pharmacokinetics and pharmacodynamics of sumatriptan in healthy volunteers. Van Hecken AM; Depré M; De Schepper PJ; Fowler PA; Lacey LF; Durham JM Br J Clin Pharmacol; 1992 Jul; 34(1):82-4. PubMed ID: 1321655 [TBL] [Abstract][Full Text] [Related]
3. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses. Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776 [TBL] [Abstract][Full Text] [Related]
4. The effect of combined therapy on the pharmacokinetics and pharmacodynamics of verapamil and propranolol in patients with angina pectoris. McCourty JC; Silas JH; Tucker GT; Lennard MS Br J Clin Pharmacol; 1988 Mar; 25(3):349-57. PubMed ID: 3358897 [TBL] [Abstract][Full Text] [Related]
5. The pharmacokinetics and pharmacodynamics of oral dofetilide after twice daily and three times daily dosing. Allen MJ; Nichols DJ; Oliver SD Br J Clin Pharmacol; 2000 Sep; 50(3):247-53. PubMed ID: 10971309 [TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics and pharmacodynamics of lisinopril and enalapril, alone and in combination with propranolol. Bendtsen F; Henriksen JH J Hum Hypertens; 1989 Jun; 3 Suppl 1():139-45. PubMed ID: 2550636 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. The Oral Sumatriptan International Multiple-Dose Study Group. Eur Neurol; 1991; 31(5):306-13. PubMed ID: 1653138 [TBL] [Abstract][Full Text] [Related]
8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions. Chen C; Bujanover S; Kareht S; Rapoport AM Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369 [TBL] [Abstract][Full Text] [Related]
9. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. Langner B; Lemmer B Eur J Clin Pharmacol; 1988; 33(6):619-24. PubMed ID: 3366165 [TBL] [Abstract][Full Text] [Related]
10. Effects of a Finnish sauna on the pharmacokinetics and haemodynamic actions of propranolol and captopril in healthy volunteers. Vanakoski J; Seppälä T Eur J Clin Pharmacol; 1995; 48(2):133-7. PubMed ID: 7589027 [TBL] [Abstract][Full Text] [Related]
11. A double-blind, randomized, crossover assessment of blood pressure following administration of avitriptan, sumatriptan, or placebo to patients with mild to moderate hypertension. Jhee SS; Salazar DE; Ford NF; Fulmor IE; Sramek JJ; Cutler NR Cephalalgia; 1999 Mar; 19(2):95-9. PubMed ID: 10214534 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects. Murdoch DL; Thomson GD; Thompson GG; Murray GD; Brodie MJ; McInnes GT Br J Clin Pharmacol; 1991 Mar; 31(3):323-32. PubMed ID: 2054272 [TBL] [Abstract][Full Text] [Related]
13. Lack of pharmacokinetic interaction between sumatriptan and naproxen. Srinivasu P; Rambhau D; Rao BR; Rao YM J Clin Pharmacol; 2000 Jan; 40(1):99-104. PubMed ID: 10631628 [TBL] [Abstract][Full Text] [Related]
14. Influence of nicardipine on the pharmacokinetics and pharmacodynamics of propranolol in healthy volunteers. Schoors DF; Vercruysse I; Musch G; Massart DL; Dupont AG Br J Clin Pharmacol; 1990 May; 29(5):497-501. PubMed ID: 2350528 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics and pharmacological actions of a long-acting formulation of propranolol. Ohashi K; Ebihara A; Kondo K; Usami M Arzneimittelforschung; 1984; 34(4):507-12. PubMed ID: 6378211 [TBL] [Abstract][Full Text] [Related]
16. Alteration of propranolol pharmacokinetics and pharmacodynamics by quinidine in man. Yasuhara M; Yatsuzuka A; Yamada K; Okumura K; Hori R; Sakurai T; Kawai C J Pharmacobiodyn; 1990 Nov; 13(11):681-7. PubMed ID: 2093126 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of long-acting propranolol 60-mg capsules: a comparative evaluation. Marino MR; Dey M; Garg DC; Jallad NS; Dorick DM; Martinez JJ; Weidler DJ J Clin Pharmacol; 1987 Nov; 27(11):885-91. PubMed ID: 3429696 [TBL] [Abstract][Full Text] [Related]
18. The pharmacokinetic and pharmacodynamic interaction between lacidipine and propranolol in healthy volunteers. Hall ST; Harding SM; Hassani H; Keene ON; Pellegatti M J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S13-7. PubMed ID: 1725444 [TBL] [Abstract][Full Text] [Related]
19. Safety, tolerability, and pharmacokinetics of sumatriptan suppositories following single and multiple doses in healthy volunteers. Kunka RL; Hussey EK; Shaw S; Warner P; Aubert B; Richard I; Fowler PA; Pakes GE Cephalalgia; 1997 Jun; 17(4):532-40. PubMed ID: 9209775 [TBL] [Abstract][Full Text] [Related]
20. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults. Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]